Free Trial

Intra-Cellular Therapies (ITCI) Insider Trading & Ownership

$65.54
-0.83 (-1.25%)
(As of 05/24/2024 ET)

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$43.93 M
Get ITCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ITCI Insider Buying and Selling by Quarter

Intra-Cellular Therapies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/11/2024Lawrence J. HinelineCFOSell10,121$65.96$667,581.16  
3/11/2024Michael HalsteadEVPSell7,345$65.97$484,549.65  
3/11/2024Sharon MatesCEOSell20,565$65.21$1,341,043.65  
3/7/2024Lawrence J. HinelineCFOSell13,132$66.60$874,591.20  
3/7/2024Sharon MatesCEOSell40,712$66.50$2,707,348.00  
3/7/2024Suresh K DurgamEVPSell6,450$66.56$429,312.00  
2/26/2024Joel S MarcusDirectorSell26,328$68.68$1,808,207.04  
2/26/2024Lawrence J. HinelineCFOSell13,337$69.43$925,987.91  
2/26/2024Michael HalsteadEVPSell7,907$69.53$549,773.71  
2/26/2024Sharon MatesCEOSell22,590$69.79$1,576,556.10  
1/18/2024Sharon MatesCEOSell67,917$65.19$4,427,509.23  
1/16/2024Sharon MatesCEOSell75,361$67.25$5,068,027.25  
1/11/2024Michael HalsteadEVPSell50,000$66.83$3,341,500.00  
1/2/2024Suresh K. DurgamEVPSell62,282$70.60$4,397,109.20  
12/13/2023Suresh K. DurgamEVPSell21,262$65.00$1,382,030.00  
11/6/2023Mark NeumannEVPSell42,393$55.63$2,358,322.59  
9/18/2023Sharon MatesCEOSell55,587$53.76$2,988,357.12  
8/7/2023Mark NeumannEVPSell55,300$58.79$3,251,087.00  
7/17/2023Suresh K DurgamEVPSell1,842$65.00$119,730.00  
6/14/2023Lawrence J. HinelineCFOSell81,854$63.97$5,236,200.38  
(Data available from 1/1/2013 forward)

ITCI Insider Trading Activity - Frequently Asked Questions

Who is on Intra-Cellular Therapies's Insider Roster?
What percentage of Intra-Cellular Therapies stock is owned by insiders?

3.40% of Intra-Cellular Therapies stock is owned by insiders. Learn more on ITCI's insider holdings.

Which Intra-Cellular Therapies insiders have been selling company stock?

The following insiders have sold ITCI shares in the last 24 months: Joel S Marcus ($2,062,307.04), Lawrence J. Hineline ($15,131,817.36), Mark Neumann ($7,563,434.74), Michael Halstead ($7,062,323.36), Nostrand Robert L Van ($2,343,900.00), Sharon Mates ($25,022,530.74), and Suresh K Durgam ($1,643,805.96).

How much insider selling is happening at Intra-Cellular Therapies?

Insiders have sold a total of 1,144,359 Intra-Cellular Therapies shares in the last 24 months for a total of $66,609,258.40 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ITCI) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners